Evidence map›Paper›PMID 24768783›Full record

ArticleClinica chimica acta; international journal of clinical chemistry2014

The vitamin E-binding protein afamin increases in maternal serum during pregnancy.

Michael Hubalek, Hannes Buchner, Manfred G Mörtl, Dietmar Schlembach, Berthold Huppertz, Branka Firulovic, Wolfgang Köhler, Erich Hafner, Benjamin Dieplinger, Ludwig Wildt and 1 more

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in Clinica chimica acta; international journal of clinical chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 47 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Evaluation of first- and third-trimester afamin levels in preeclampsia.Revista da Associacao Medica Brasileira (1992) · 2023
    Article
  7. Novel Biomolecules in the Pathogenesis of Gestational Diabetes Mellitus 2.0.International journal of molecular sciences · 2022
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Afamin: an early predictor of preeclampsia.Archives of gynecology and obstetrics · 2018
    Article
  18. Is Afamin a novel biomarker for gestational diabetes mellitus? A pilot study.Reproductive biology and endocrinology : RB&E · 2018
    Article
  19. Complexity of vitamin E metabolism.World journal of biological chemistry · 2016
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Michael HubalekDepartment of Gynecology and Obstetrics, Innsbruck Medical University, Innsbruck, Austria.
Hannes BuchnerInstitute of Medical Informatics, Biometry and Epidemiology, Medical School, Ludwig Maximilian University of Munich, Germany.
Manfred G MörtlDepartment of Gynecology and Obstetrics, Medical University of Graz, Austria.
Dietmar SchlembachDepartment of Gynecology and Obstetrics, Medical University of Graz, Austria; Department of Gynecology and Obstetrics, Jena University, Jena, Germany.
Berthold HuppertzInstitute of Cell Biology, Histology and Embryology, Medical University of Graz, Austria.
Branka FirulovicDepartment of Gynecology and Obstetrics, Innsbruck Medical University, Innsbruck, Austria.
Wolfgang KöhlerDepartment of Laboratory Medicine, Konventhospital Barmherzige Brüder, Linz, Austria.
Erich HafnerDepartment of Obstetrics and Gynecology, Danube Hospital/SMZ-Ost, Vienna, Austria.
Benjamin DieplingerDepartment of Laboratory Medicine, Konventhospital Barmherzige Brüder, Linz, Austria.
Ludwig WildtDepartment of Gynecological Endocrinology and Reproductive Medicine, Innsbruck Medical University, Innsbruck, Austria.
Hans DieplingerDivision of Genetic Epidemiology, Department of Medical Genetics, Clinical and Molecular Pharmacology, Innsbruck Medical University, Innsbruck, Austria; Vitateq Biotechnology GmbH, Innsbruck, Austria. Electronic address: hans.dieplinger@i-med.ac.at.
Innsbruck Medical University · ATMedical University of Graz · ATConvent Hospital of the Brothers of Saint John of God · ATUniversität für Weiterbildung Krems · ATZimmer Biomet (Germany) · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAfamin is a liver-derived plasma glycoprotein with vitamin E-binding properties and a putative function in fertility. This study evaluated serum afamin concentrations during and postpartum to uncomplicated pregnancies and investigated a potential association between afamin concentrations and pregnancy outcome.

methodsAfamin serum concentrations were measured in women with uncomplicated pregnancies in a retrospective cohort (n=466) at different gestational ages and a prospective observational study (n=76) in the first, second and third trimester. Furthermore, afamin was determined in the first trimester in a cross-sectional pilot study including women with preeclampsia (PE), pregnancy-induced hypertension (PIH) and women without pregnancy complications (n=13 each). Finally, expression of afamin was investigated in human placental tissue by RT-PCR and immunohistochemistry.

resultsAfamin concentrations increased linearly almost two-fold during pregnancy in both retrospective and prospective studies in women without pregnancy complications with median afamin serum concentrations of 61.9 mg/l, 79.6 mg/l, and 98.6 mg/l in the first, second, and third trimester, respectively. After delivery, median afamin concentrations decreased to baseline values of 54.6 mg/l. In the pilot study with pregnancy complications, women with PE displayed significantly higher median afamin concentrations than did women with uncomplicated pregnancy (70.0 mg/l vs. 55.4 mg/l, P=0.007). Expression analyses revealed no placental afamin expression at either mRNA or protein level in uncomplicated pregnancy.

conclusionA linear increase in the maternally expressed glycoprotein afamin during pregnancy may serve as basic reference for subsequent investigations of afamin in pregnancy-related disorders.

Indexed as

AdultCarrier ProteinsCross-Sectional StudiesFemaleGene Expression RegulationGlycoproteinsHumansPilot ProjectsPre-EclampsiaPregnancyPregnancy TrimestersRetrospective StudiesSerum AlbuminSerum Albumin, HumanVitamin EYoung AdultAFM protein, humanCarrier ProteinsGlycoproteinsSerum AlbuminSerum Albumin, HumanVitamin EAfamin in pregnancymaternal expressionpreeclampsiapregnancy complications

Identifiers

PMID24768783
PMCPMC4065568
OpenAlexW2057819437

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.